Rh (D) alloimmunization treated by double filtration plasmapheresis.

Clicks: 337
ID: 79807
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Here in this report a 31 year old pregnant woman with positive serum antiglobulin test against anti-D antierythrocyte antibodies who was treated succesfully with double filtration plasmapheresis (DFPP) is presented. The DFPP was started in the early stage of pregnancy together with intravenous immunoglobulin therapy and the antierythrocyte antibody titer of the patient was successfully maintained in a stable level below 1:64 dilution. She delivered successfully on the 30th week of gestation. The favorable outcome of this patient implies that DFPP is an effective and safe treatment modality in pregnant women with red cell alloimmunization.
Reference Key
bek2019rhtransfusion Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bek, Sibel Gokcay;Eren, Necmi;Uzay, Ant;Bakirdogen, Serkan;
Journal Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Year 2019
DOI
S1473-0502(18)30099-5
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.